Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice

2010 ◽  
Vol 33 (8) ◽  
pp. 579-586 ◽  
Author(s):  
E. Papini ◽  
R. Negro ◽  
A. Pinchera ◽  
R. Guglielmi ◽  
A. Baroli ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Clinical Practice ◽  
Thyroid Nodule ◽  
Differentiated Thyroid Cancer ◽  
Italian Association ◽  
Cancer Management ◽  
Joint Statement ◽  
In Pregnancy

A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines

Thyroid ◽  
2020 ◽  
Vol 30 (1) ◽  
pp. 25-33 ◽  
Author(s):  
Anna M. Sawka ◽  
Anna R. Gagliardi ◽  
Megan R. Haymart ◽  
Cord Sturgeon ◽  
Victor Bernet ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Clinical Practice ◽  
Thyroid Nodule ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Differentiated Thyroid Cancer ◽  
American Thyroid Association

scholarly journals 2016 Russian clinical practice guidelines for differentiated thyroid cancer diagnosis and treatment

2017 ◽  
Vol 11 (1) ◽  
pp. 6-27 ◽  
Author(s):  
Dmitriy G. Beltsevich ◽  
Vladimir E. Vanushko ◽  
Pavel O. Rumiantsev ◽  
Galina A. Melnichenko ◽  
Nikolay S. Kuznetsov ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Clinical Practice ◽  
Cancer Diagnosis ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Differentiated Thyroid Cancer ◽  
Diagnosis And Treatment

В представленных клинических рекомендациях обсуждаются современные подходы к диагностике и лечению дифференцированного рака щитовидной железы у взрослых. Изменения в настоящей редакции Клинических рекомендаций касаются показаний к пункционной биопсии, скринингового определения концентрации кальцитонина, унификации заключений цитологического исследования, новых подходах к послеоперационной динамической стратификации риска рецидива, показаний к супрессивной и заместительной терапии, таргетной терапии йоднегативных форм дифференцированного рака щитовидной железы.

The role of ablative treatment in differentiated thyroid cancer management

2017 ◽  
Vol 12 (2) ◽  
pp. 109-116 ◽  
Author(s):  
Miguel Melo ◽  
Nuno Vicente ◽  
Mara Ventura ◽  
Adriana Gaspar Da Rocha ◽  
Paula Soares ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Differentiated Thyroid Cancer ◽  
Cancer Management

scholarly journals Management of differentiated thyroid cancer diagnosed during pregnancy

1999 ◽  
pp. 404-406 ◽  
Author(s):  
L Vini ◽  
S Hyer ◽  
B Pratt ◽  
C Harmer
Keyword(s):  
Thyroid Cancer ◽  
Bone Metastases ◽  
Differentiated Thyroid Cancer ◽  
Subtotal Thyroidectomy ◽  
Second Trimester ◽  
Original Cohort ◽  
Well Differentiated ◽  
Disease Free ◽  
In Pregnancy

OBJECTIVE: To assess the outcome of thyroid cancer diagnosed during pregnancy. DESIGN: Retrospective analysis of patients diagnosed between 1949 and 1997 with thyroid cancer presenting during pregnancy. RESULTS: Nine women with a median age of 28 years were identified. A thyroid nodule was discovered by the clinician during routine antenatal examination in four cases, the remainder had noted a lump in the neck. In all patients, the nodule was reported to almost double in size during the pregnancy. One patient underwent subtotal thyroidectomy during the second trimester; eight were operated on within 3 to 10 months from delivery. Total thyroidectomy was performed in five and subtotal thyroidectomy in four. All tumours were well differentiated and ranged in size from 1 to 6 cm. OUTCOME: The median follow-up was 14 years (5-31 years). One patient relapsed locally requiring further surgery. One patient developed bone metastases dying 7 years after presentation; her planned treatment had been delayed because of an intervening pregnancy. Eight of the original cohort of patients are currently disease free. CONCLUSIONS: Differentiated thyroid cancer presenting in pregnancy generally has an excellent prognosis. When the disease is discovered early in pregnancy, surgery should be considered in the second trimester but radioiodine scans and treatment can be safely delayed until after delivery. In all cases, treatment should not be delayed for more than a year.

Serum Thyroglobulin Improves the Sensitivity of the McGill Thyroid Nodule Score for Well-Differentiated Thyroid Cancer

Thyroid ◽  
2014 ◽  
Vol 24 (5) ◽  
pp. 852-857 ◽  
Author(s):  
Patrick Scheffler ◽  
Veronique I. Forest ◽  
Rebecca Leboeuf ◽  
Anca V. Florea ◽  
Michael Tamilia ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Thyroid Nodule ◽  
Differentiated Thyroid Cancer ◽  
Serum Thyroglobulin ◽  
Well Differentiated

Emerging Trends in Differentiated Thyroid Cancer Management

2006 ◽  
Vol 135 (2_suppl) ◽  
pp. P70-P70
Author(s):  
David L Steward ◽  
R Michael Tuttle ◽  
Robert A Sofferman ◽  
James A Fagin
Keyword(s):  
Thyroid Cancer ◽  
Differentiated Thyroid Cancer ◽  
Cancer Management ◽  
Emerging Trends

scholarly journals Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus

2013 ◽  
Vol 57 (4) ◽  
pp. 240-264 ◽  
Author(s):  
Pedro Weslley Rosário ◽  
Laura S. Ward ◽  
Gisah A. Carvalho ◽  
Hans Graf ◽  
Rui M. B. Maciel ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Clinical Practice ◽  
Mortality Rate ◽  
Disease Management ◽  
Clinical Relevance ◽  
Conventional Treatment ◽  
Differentiated Thyroid Cancer ◽  
Thyroid Nodules ◽  
Relevant Literature ◽  
Aggressive Disease

Thyroid nodules are frequent findings, especially when sensitive imaging methods are used. Although thyroid cancer is relatively rare, its incidence is increasing, particularly in terms of small tumors, which have an uncertain clinical relevance. Most patients with differentiated thyroid cancer exhibit satisfactory clinical outcomes when treatment is appropriate, and their mortality rate is similar to that of the overall population. However, relapse occurs in a considerable fraction of these patients, and some patients stop responding to conventional treatment and eventually die from their disease. Therefore, the challenge is how to identify the individuals who require more aggressive disease management while sparing the majority of patients from unnecessary treatments and procedures. We have updated the Brazilian Consensus that was published in 2007, emphasizing the diagnostic and therapeutic advances that the participants, representing several Brazilian university centers, consider most relevant in clinical practice. The formulation of the present guidelines was based on the participants' experience and a review of the relevant literature.

Sign in / Sign up

Export Citation Format

Share Document